Before you sell to, join or invest in Oligomerix, Inc.
MentionFox check on Oligomerix, Inc.: only 1 source on file so far (checked 8 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/oligomerix-inc-form-d-24000001
Check Oligomerix, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Oligomerix, Inc. filed a Form D with the Securities and Exchange Commission on 2024-12-06.
Oligomerix, Inc. filed a Form D notice of an exempt securities offering with the SEC on December 6, 2024. The filing reports $75K sold. Its industry group is Pharmaceuticals. It names James Moe (Executive Officer, Director), Eliot Davidowitz (Executive Officer, Director), William Erhardt (Executive Officer, Director) (SEC Form D, December 6, 2024).
Is this your company?
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Sell to companies like Oligomerix, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2024-12-06 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Oligomerix, Inc.
Free to see. No signup.
Get an email when Oligomerix, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Oligomerix, Inc. raises, hires or launches. No email unless you switch it on.
Watch Oligomerix, Inc. →Get the full cited report on Oligomerix, Inc.
What the filing shows about Oligomerix, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Oligomerix, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Oligomerix, Inc.'s address as 2 Westchester Park Drive, Suite 208, White Plains, NY 10604.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Oligomerix, Inc. is a registered filer with the SEC (CIK 1543843) and has filed since 2024-12-06. 1 filing is on record, the latest on 2024-12-06.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Oligomerix, Inc.'s Form D of 2024-12-06 names James Moe, Eliot Davidowitz, William Erhardt and 5 more as its officers, directors or promoters.
Its new offerings report $75K sold across 1 offering, as its own filings state.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
James Moe is named as Executive Officer and Director on the Form D that Oligomerix, Inc. filed with the SEC on 6 December 2024, one of 8 people that filing names.
Eliot Davidowitz is named as Executive Officer and Director on the Form D that Oligomerix, Inc. filed with the SEC on 6 December 2024, one of 8 people that filing names.
William Erhardt is named as Executive Officer and Director on the Form D that Oligomerix, Inc. filed with the SEC on 6 December 2024, one of 8 people that filing names.
Jack Pasini is named as Executive Officer and Director on the Form D that Oligomerix, Inc. filed with the SEC on 6 December 2024, one of 8 people that filing names.
Robert Foerster is named as Executive Officer and Director on the Form D that Oligomerix, Inc. filed with the SEC on 6 December 2024, one of 8 people that filing names.
David Dantzker is named as Director on the Form D that Oligomerix, Inc. filed with the SEC on 6 December 2024, one of 8 people that filing names.
Douglas Durand is named as Director on the Form D that Oligomerix, Inc. filed with the SEC on 6 December 2024, one of 8 people that filing names.
Jeffrey Bluestein is named as Director on the Form D that Oligomerix, Inc. filed with the SEC on 6 December 2024, one of 8 people that filing names.
8 people named on the filing — 5 holding an executive role and 3 as directors only.
Named as of the 2024-12-06 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Oligomerix, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Oligomerix, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Oligomerix, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Oligomerix, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Oligomerix, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Oligomerix, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in New York
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/oligomerix-inc-form-d-24000001